SEC Form 4 · accession 0001209191-19-018968
NEKTAR THERAPEUTICS · NKTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
R Scott Greer
Director
Period of report
Mar 8, 2019
Accepted (ET)
Mar 12, 2019 · 6:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000906709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 8, 2019 | M | 10,000 | $5.14 | A | 145,083 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $5.14 | Mar 8, 2019 | M | 10,000 | D | Sep 30, 2012 | Sep 12, 2019 | Common Stock | 10,000 | 0 | D |